Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration
Journal of Nephropathology · 05.02.2017 · 6 (3) · 134-137
DOI: 10.15171/jnp.2017.23 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Nephropathology, online erschienen am 05.02.2017. Verfasst von Gebran Khneizer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
Zitieren
APA
Khneizer, G., Al-Taee, A., & Bastani, B. (2017). Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration. Journal of Nephropathology, 6(3), 134-137. https://doi.org/10.15171/jnp.2017.23
Vancouver
Khneizer G, Al-Taee A, Bastani B. Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration. Journal of Nephropathology. 2017;6(3):134-137. doi:10.15171/jnp.2017.23
BibTeX
@article{Khneizer2017,
author = {Khneizer, Gebran and Al-Taee, Ahmad and Bastani, Bahar},
title = {Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration},
journal = {Journal of Nephropathology},
year = {2017},
volume = {6},
number = {3},
pages = {134--137},
doi = {10.15171/jnp.2017.23}
}
EUVIMED